138 related articles for article (PubMed ID: 7542382)
1. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation.
Crandall BF; Chua C
Prenat Diagn; 1995 Apr; 15(4):339-43. PubMed ID: 7542382
[TBL] [Abstract][Full Text] [Related]
2. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
[TBL] [Abstract][Full Text] [Related]
3. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Wald N; Cuckle H; Nanchahal K
Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
[TBL] [Abstract][Full Text] [Related]
4. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.
Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of neural tube defects: experiences with acetylcholinesterase gel electrophoresis.
Crandall BF; Kasha W; Matsumoto M
Am J Med Genet; 1982 Jul; 12(3):361-6. PubMed ID: 6180640
[TBL] [Abstract][Full Text] [Related]
8. Risks for fetal abnormalities after very and moderately elevated AF-AFPs.
Crandall BF; Chua C
Prenat Diagn; 1997 Sep; 17(9):837-41. PubMed ID: 9316128
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
Crandall BF; Kulch P; Tabsh K
Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
[TBL] [Abstract][Full Text] [Related]
10. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience].
Guibaud S; Capella-Bonnet M; Simplot A
J Genet Hum; 1985 Sep; 33(3-4):339-45. PubMed ID: 2414399
[TBL] [Abstract][Full Text] [Related]
12. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
Crandall BF; Matsumoto M
Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
[TBL] [Abstract][Full Text] [Related]
13. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
[TBL] [Abstract][Full Text] [Related]
14. Amniotic fluid alpha-fetoprotein and acetylcholinesterase in early genetic amniocentesis.
Drugan A; Syner FN; Greb A; Evans MI
Obstet Gynecol; 1988 Jul; 72(1):35-8. PubMed ID: 2454439
[TBL] [Abstract][Full Text] [Related]
15. Amniotic-fluid acetylcholinesterase as a possible diagnostic test for neural-tube defects in early pregnancy.
Smith AD; Wald NJ; Cuckle HS; Stirrat GM; Bobrow M; Lagercrantz H
Lancet; 1979 Mar; 1(8118):685-8. PubMed ID: 85932
[TBL] [Abstract][Full Text] [Related]
16. Antenatal screening in Oxford for fetal neural tube defects.
Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical markers of neural tube closure defects during the second half of pregnancy].
Guibaud S; Boisson C; Simplot A; Thoulon JM
J Genet Hum; 1988 Aug; 36(4):337-46. PubMed ID: 2464664
[TBL] [Abstract][Full Text] [Related]
18. Cut-off levels for maternal plasma alpha-fetoprotein in the diagnosis of neural tube defects: validation of the use of multiples of the normal median.
Tovey KC; Gerson M
Br J Obstet Gynaecol; 1979 Jul; 86(7):507-15. PubMed ID: 89862
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of amniotic acetylcholinesterase analysis in the diagnosis of fetal abnormality in 3700 pregnancies.
Aitken DA; Morrison NM; Ferguson-Smith MA
Prenat Diagn; 1984; 4(5):329-40. PubMed ID: 6209698
[TBL] [Abstract][Full Text] [Related]
20. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
